These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6108461)

  • 21. Current concepts in the management of hemophilia.
    Abildgaard CF
    Semin Hematol; 1975 Jul; 12(3):223-32. PubMed ID: 1079631
    [No Abstract]   [Full Text] [Related]  

  • 22. Current concepts in the management of hemophilia.
    Karayalcin G
    Pediatr Ann; 1985 Sep; 14(9):640-2, 644-5, 648-53 passim. PubMed ID: 3932946
    [No Abstract]   [Full Text] [Related]  

  • 23. Musculoskeletal bleeding in hemophilia.
    Greer RB; Ballard JO
    Pediatr Ann; 1982 Jun; 11(6):521-4, 526-7. PubMed ID: 6808447
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemophilia. Current concepts in management.
    Green D; Smith NJ
    Med Clin North Am; 1972 Jan; 56(1):105-17. PubMed ID: 4550184
    [No Abstract]   [Full Text] [Related]  

  • 25. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
    Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
    [No Abstract]   [Full Text] [Related]  

  • 26. Delivery of care to hemophilic children: home care versus hospitalization.
    Strawczynski H; Stachewitsch A; Morgenstern G; Shaw ME
    Pediatrics; 1973 Jun; 51(6):986-91. PubMed ID: 4710458
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
    Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
    Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The practical management of haemophilia.
    Winter M
    Blood Rev; 1992 Sep; 6(3):174-81. PubMed ID: 1422286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
    Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
    Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
    [No Abstract]   [Full Text] [Related]  

  • 31. Clotting factor concentrates for resistant haemophilia.
    Bloom AL
    Br J Haematol; 1978 Sep; 40(1):21-7. PubMed ID: 361064
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-factor VIII anamnesis after factor IX complex.
    Palascak JE; Shapiro SR
    N Engl J Med; 1977 Dec; 297(25):1403. PubMed ID: 927458
    [No Abstract]   [Full Text] [Related]  

  • 33. Comprehensive management of haemophilia.
    Kasper CK; Dietrich SL
    Clin Haematol; 1985 Jun; 14(2):489-512. PubMed ID: 3930117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in hemophilia: experimental aspects and therapy.
    Rodriguez NI; Hoots WK
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):181-98. PubMed ID: 20113902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
    Sharp HK; McIlveen LP; Schuman NJ
    Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemophilia, a changed picture].
    Breederveld C; ten Cate JW; Sixma JJ; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1976 Jan; 120(2):69-70. PubMed ID: 1250448
    [No Abstract]   [Full Text] [Related]  

  • 37. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
    Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
    Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis in patients with haemophilia: introduction.
    Chambost H
    Haemophilia; 2010 Mar; 16 Suppl 2():1-3. PubMed ID: 20132331
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
    Iizuka A; Kuwashima M; Nagao T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
    [No Abstract]   [Full Text] [Related]  

  • 40. Conjectures on factor VIII bypassing activity.
    Aronson DL
    Prog Clin Biol Res; 1981; 72():103-21. PubMed ID: 6977778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.